Synovus Financial’s Histogen Inc. Common Stock HSTO Stock Holding History

Synovus Financial’s Portfolio HSTO Stock Details HSTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10,050	Closed	-$5.17K	–	893
2023 Q3	$5.17K	Hold	10,050	–	–	﹤0.01%	837
2023 Q2	$7.15K	Buy	+10,050	New	+$9K	﹤0.01%	839
2022 Q2	–	Sell	-2,550	Closed	-$13K	–	888
2022 Q1	$13K	Buy	2,550 +1,500	+143%	+$7.59K	﹤0.01%	840
2021 Q4	$7K	Buy	+1,050	New	+$12K	﹤0.01%	854

Other funds holding HSTO

HCM

Highlander Capital Management Short Hills, New Jersey $292M AUM 22.24% 1-Year Est. Return

Synovus Financial's HSTO Position: Q4 2023 in Review

Synovus Financial sold out of Histogen Inc. Common Stock (HSTO) in Q4 2023, closing a stake of 10,050 shares — an estimated $5.17K sold.

Synovus Financial first reported a position in HSTO in Q4 2021 and held it in 4 quarters. The position peaked at $13K in Q1 2022. 1 fund tracked by Wall St. Rank holds HSTO as of Q4 2023.

Synovus Financial reported no remaining Histogen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Synovus Financial sold 10,050 Histogen Inc. Common Stock shares in Q4 2023, an estimated $5.17K.
Synovus Financial first reported a position in Histogen Inc. Common Stock in Q4 2021 and held it in 4 quarters.
Synovus Financial's Histogen Inc. Common Stock position peaked at $13K in Q1 2022.
1 fund tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q4 2023.

Based on Synovus Financial's 13F filing for Q4 2023, filed 14 Feb 2024.